Changes in Pulmonary Function Tests After Neoadjuvant Therapy Predict Postoperative Complications

Annals of Thoracic Surgery

Volumn 88, Issue 3, 2009, Pages 930-936

  Cerfolio, Robert J ^a   Talati, Amar ^a   Bryant, Ayesha S ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CARBOPLATIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ATELECTASIS; BRAIN INJURY; BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CARDIOGENIC SHOCK; CHEST TIGHTNESS; CONSTIPATION; CONTROLLED STUDY; DATA BASE; DYSPNEA; ELECTIVE SURGERY; FEMALE; FORCED EXPIRATORY VOLUME; HEART ATRIUM ARRHYTHMIA; HEART INFARCTION; HOARSENESS; HUMAN; HYPOTENSION; HYPOXIA; INDEPENDENT VARIABLE; KIDNEY FAILURE; LUNG ALVEOLUS; LUNG DIFFUSION CAPACITY; LUNG EDEMA; LUNG FUNCTION TEST; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORBIDITY; MULTIVARIATE ANALYSIS; PAIN; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SOMNOLENCE; STROKE; SUBCUTANEOUS EMPHYSEMA; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT DURATION; URINE RETENTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LUNG; LUNG NEOPLASMS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PACLITAXEL; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PULMONARY ALVEOLI; PULMONARY DIFFUSING CAPACITY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RISK ASSESSMENT;

EID: 68849112356     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.06.013     Document Type: Article

References (22)

1. Cerfolio R.J., Maniscalco L., and Bryant A.S. The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Ann Thorac Surg 86 (2008) 912-920
2. Ferguson M.K., Lehman A.G., Billiger C.T., and Brunelli A. The role of diffusing capacity and exercise tests. [Review]. Thorac Surg Clin 18 (2008) 9-17
3. Ferguson M.K., and Vigneswaran W.T. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 85 (2008) 1158-1165
4. 1 and Dlco after major lung resection: a prospective evaluation at different postoperative periods. Ann Thorac Surg 83 (2007) 1134-1139
5. Boushy S.F., Helgason A.H., Billig D.M., et al. Clinical, physiologic, and morphologic examination of the lung in patients with bronchogenic carcinoma and the relation of the findings to postoperative deaths. Am Rev Respir Dis 101 (1970) 685-695
6. Fowler W.C., Langer C.J., Curran Jr. W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
7. Dimopoulou I., Galani H., Dafni U., Samakovli A., Roussos C., and Dimopoulos M.A. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin. Cancer 94 (2002) 452-458
8. Rivera M.P., Detterbeck F.C., Socinski M.A., et al. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Chest 135 (2009) 1588-1595
9. Leo F., Solli P., Spaggiari L., et al. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?. Ann Thorac Surg 77 (2004) 260-265
10. Takeda S., Funakoshi Y., Kadota Y., et al. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?. Ann Thorac Surg 82 (2006) 232-236
11. Abou-Jawde R.M., Mekhail T., Adelstein D.J., et al. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 128 (2005) 250-255
12. Cerfolio R.J., and Bryant A.S. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity. Ann Thorac Surg 88 (2009) 405-411
13. Levitzky M. Pulmonary physiology. 5th ed. (1999), McGraw-Hill, New York Chapters 1, 3, 6, 7.
14. Goldman H., and Becklake M. Respiratory function tests. Am Rev Tuberc Pulm Dis 79 (1959) 457-467
15. Ramanathan R.K., Reddy V.V., Holbert J.M., and Belani C.P. Pulmonary infiltrates following administration of paclitaxel. Chest 110 (1996) 289-292
16. Khan A., McNally D., Tutschka P.J., and Bilgrami S. Paclitaxel induced acute bilateral pneumonitis. Ann Pharmacother 31 (1997) 1471-1474
17. Fujimori K., Yokomama A., Kurita Y., Uno K., and Saijo N. Paclitaxel induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy. Oncology 55 (1998) 340-344
18. Martin J., Ginsberg R.J., Abolhoda A., Bains M.S., Downey R.J., and Korst R.J. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
19. Cerfolio R.J., Bryant A.S., Spencer S.A., and Bartolucci A.A. Pulmonary resection after high dose and low dose chest irradiation. Ann Thorac Surg 80 (2005) 1224-1230
20. DeJaeger K., Seppenwoolde Y., Boersma L.J., et al. Pulmonary function following high-dose radiotherapy of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 1331-1340
21. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39 (1997) 563-570
22. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for standard technique-1995 update. Am J Respir Crit Care Med 152 (1995) 2185-2198